Ayomide Akinnusi

A selectivity-aware machine-learning workflow for prioritizing CDK2-biased kinase inhibitor candidates

Abstract Cyclin-dependent kinase 2 (CDK2) is a therapeutic target of interest, but selective inhibition remains challenging because ATP-competitive inhibitors often engage related CDK family members. Here, we developed a selectivity-aware computational workflow to prioritize CDK2...